ISRG
Price
$474.26
Change
+$5.82 (+1.24%)
Updated
Aug 26 closing price
Capitalization
170.01B
50 days until earnings call
NTRA
Price
$165.71
Change
+$3.24 (+1.99%)
Updated
Aug 26 closing price
Capitalization
22.74B
70 days until earnings call
Interact to see
Advertisement

ISRG vs NTRA

Header iconISRG vs NTRA Comparison
Open Charts ISRG vs NTRABanner chart's image
Intuitive Surgical
Price$474.26
Change+$5.82 (+1.24%)
Volume$2.93M
Capitalization170.01B
Natera
Price$165.71
Change+$3.24 (+1.99%)
Volume$1.01M
Capitalization22.74B
ISRG vs NTRA Comparison Chart in %
Loading...
ISRG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ISRG vs. NTRA commentary
Aug 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ISRG is a Buy and NTRA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 27, 2025
Stock price -- (ISRG: $474.26 vs. NTRA: $165.71)
Brand notoriety: ISRG: Notable vs. NTRA: Not notable
ISRG represents the Pharmaceuticals: Other, while NTRA is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ISRG: 155% vs. NTRA: 71%
Market capitalization -- ISRG: $170.01B vs. NTRA: $22.74B
ISRG [@Pharmaceuticals: Other] is valued at $170.01B. NTRA’s [@Medical Specialties] market capitalization is $22.74B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $170.01B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.04B. The average market capitalization across the [@Medical Specialties] industry is $10.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ISRG’s FA Score shows that 0 FA rating(s) are green whileNTRA’s FA Score has 0 green FA rating(s).

  • ISRG’s FA Score: 0 green, 5 red.
  • NTRA’s FA Score: 0 green, 5 red.
According to our system of comparison, NTRA is a better buy in the long-term than ISRG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ISRG’s TA Score shows that 4 TA indicator(s) are bullish while NTRA’s TA Score has 5 bullish TA indicator(s).

  • ISRG’s TA Score: 4 bullish, 5 bearish.
  • NTRA’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, both ISRG and NTRA are a bad buy in the short-term.

Price Growth

ISRG (@Pharmaceuticals: Other) experienced а -1.03% price change this week, while NTRA (@Medical Specialties) price change was +3.49% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.63%. For the same industry, the average monthly price growth was +2.21%, and the average quarterly price growth was +21.82%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.44%. For the same industry, the average monthly price growth was +14.04%, and the average quarterly price growth was +8.53%.

Reported Earning Dates

ISRG is expected to report earnings on Oct 16, 2025.

NTRA is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.63% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical Specialties (+0.44% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ISRG($170B) has a higher market cap than NTRA($22.7B). NTRA YTD gains are higher at: 4.681 vs. ISRG (-9.139). ISRG has higher annual earnings (EBITDA): 3.17B vs. NTRA (-211.86M). ISRG has more cash in the bank: 5.33B vs. NTRA (1.02B). ISRG has less debt than NTRA: ISRG (87M) vs NTRA (196M). ISRG has higher revenues than NTRA: ISRG (9.15B) vs NTRA (1.96B).
ISRGNTRAISRG / NTRA
Capitalization170B22.7B749%
EBITDA3.17B-211.86M-1,497%
Gain YTD-9.1394.681-195%
P/E Ratio66.15N/A-
Revenue9.15B1.96B466%
Total Cash5.33B1.02B524%
Total Debt87M196M44%
FUNDAMENTALS RATINGS
ISRG vs NTRA: Fundamental Ratings
ISRG
NTRA
OUTLOOK RATING
1..100
1320
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
58
Fair valued
PROFIT vs RISK RATING
1..100
3439
SMR RATING
1..100
5296
PRICE GROWTH RATING
1..100
6344
P/E GROWTH RATING
1..100
77100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NTRA's Valuation (58) in the Biotechnology industry is in the same range as ISRG (90) in the Medical Specialties industry. This means that NTRA’s stock grew similarly to ISRG’s over the last 12 months.

ISRG's Profit vs Risk Rating (34) in the Medical Specialties industry is in the same range as NTRA (39) in the Biotechnology industry. This means that ISRG’s stock grew similarly to NTRA’s over the last 12 months.

ISRG's SMR Rating (52) in the Medical Specialties industry is somewhat better than the same rating for NTRA (96) in the Biotechnology industry. This means that ISRG’s stock grew somewhat faster than NTRA’s over the last 12 months.

NTRA's Price Growth Rating (44) in the Biotechnology industry is in the same range as ISRG (63) in the Medical Specialties industry. This means that NTRA’s stock grew similarly to ISRG’s over the last 12 months.

ISRG's P/E Growth Rating (77) in the Medical Specialties industry is in the same range as NTRA (100) in the Biotechnology industry. This means that ISRG’s stock grew similarly to NTRA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ISRGNTRA
RSI
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 3 days ago
66%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
65%
Bearish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
58%
Bullish Trend 3 days ago
87%
MACD
ODDS (%)
Bullish Trend 1 day ago
54%
Bullish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
60%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
63%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 10 days ago
72%
Bullish Trend 6 days ago
81%
Declines
ODDS (%)
Bearish Trend 21 days ago
58%
Bearish Trend 9 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
61%
Bearish Trend 3 days ago
82%
Aroon
ODDS (%)
Bearish Trend 1 day ago
61%
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ISRG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GHYG46.310.06
+0.12%
iShares US & Intl High Yield Corp Bd ETF
OVB20.520.02
+0.12%
Overlay Shares Core Bond ETF
MINT100.630.02
+0.02%
PIMCO Enhanced Short Maturity Active ETF
IGR4.96-0.01
-0.20%
CBRE Global Real Estate Income Fund
QNXT26.17-0.20
-0.75%
iShares Nasdaq-100 ex Top 30 ETF

NTRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTRA has been loosely correlated with VCYT. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if NTRA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTRA
1D Price
Change %
NTRA100%
+1.99%
VCYT - NTRA
56%
Loosely correlated
-1.62%
GH - NTRA
55%
Loosely correlated
+2.50%
ISRG - NTRA
53%
Loosely correlated
+1.24%
GKOS - NTRA
47%
Loosely correlated
+2.45%
TWST - NTRA
46%
Loosely correlated
+1.20%
More